This article focuses on bacteriophage P4 as a potential peptide display phage by exploring the possibility of using the P4 eapsid decoration component, Psu, as a peptide carrier protein. Psu is non-essential for P4 growth but it enhances the stability of the P4 capsid by binding to its exterior. We have constructed a unique Sacl cloning site in the beginning of the psu gene. This site changes the third amino acid of Psu from Ser to Leu. This substitution does not destroy the binding of Psu to the P4 capsid. A synthetic oligonucleotide encoding a 10-amino acid peptide whose sequence is part of the human p62 c'myc protein, has been inserted into the SacI site. The PSUc.my c shows full capsid binding activity and reacts with monoclonal antibodies directed against the c-myc peptide. These results pave the way for the further development of a peptide display system based on bacteriophage P4.
The P2.P4 phage system
The P2-P4 phage system of Escherichia coli, which consists of satellite phage P4 and its helper P2, exerts a set of regulatory interactions at the genome level as well as the level of capsid assembly. The capsid of phage P4 is 45 nm in diameter (T = 4) and contains a linear dsDNA genome of 11.3 kb, while the P2 eapsid has a diameter of 60 nm (T = 7) with a linear dsDNA genome of 33.3 kb [!] . They have identical tails. The P4 genome contains replication and regulatory genes but lacks structural genes and uses P2 as a helper to obtain the tail and capsid components. Aspects of genome propagation and helper exploitation by P4 has recently been reviewed [2] . The P2 N gene codes for the capsid protein N (357 amino acids), which is processed during P2 capsid formation by removal of 31 amino acids from the amino-terminal end (N * ). In the case of P4 this processing reaction results in two partially processed N versions, called hl and h2, in addition to N *. hl and h2 are assumed to reside in the P4 hexamer [1, 3] . Furthermore, the P4 psu gene product decorates the mature P4 capsid by binding (probably as a direct) at the top of each of its 30 hexamers ( Fig. 1 ) [4] and makes it more robust [5] . Psu, however, is not essential for P4 propagation. The psu geae was first recognized as coding for a function relieving polar effects of certain amber mutations in phage P2 [6] . This relief is due to a Psu-exerted anti-termination of transcription [7, 8] .
Our laboratory is studying the morphogenesis of P2 and P4 with special reference to the mechanism of capsid size determination. At the EMBO-FEMS meeting on Bacterial Viruses: Molecular Biology and Biotechnology (27-30 March 1994, Gargnano, Italy), we presented data describing the identification of the P2 and P4 portal protein. We also discussed the use of phage P4 as a potential peptide display system. In this review of our presentations at Gargnano, we discuss data on this more applicative aspect of P4. The portal work has recently been published elsewhere [9] .
Phage display
The last few years have witnessed a rapid progress in the development and application of peptide display by filamentous phages ( [10] [11] [12] this volume). After appropriate design these phages permit display of peptides on their coat surface as part of the major coat protein (gpa) or as part of a minor coat component (gp3) [13] . These systems are now part of the tool kit used in the exploration of molecular diversity with combinatorial shape libraries [14] . The filamentous phages have the advantage of being very robust and easy to handle. When displaying peptides, however, they may suffer from certain constraints like reduced infectivity (gp3 is part of the infectious device), selective cell release as well as some other limitations [13] . These phenomena might result in failure to display interesting peptides. To explore the possibility of using phage P4 as a peptide display system, we have focused on the P4 psu gene product as a display protein. Since Psu is not part of the infecting device, the tail, and the release of P4 particles occurs by cell lysis, peptide display by P4 should not suffer from reduced particle infectivity nor from selective cell release. By comparing the amino acid sequences of Psu from P4 and its homolog of phage 0R73, the two proteins differ in just a few amino acids at the beginning of the amino-terminal end (Met-Glu-Ser-Thr-Ala-Leu-for Psur4 and Met-Thr-Thr-Met-Ser-Leu-for PSUOR73) [15] [16] [17] . The fact that the PSU0R73 protein exerts the polarity suppression function (E.W. Six, personal communication) and binds to P4Psu-capsids [18] suggests that Psup4 may tolerate amino acid changes in the amino-terminal end without affecting neither its anti-termination function nor its P4 hexamer binding property.
Construction of a P4 genome with a unique cloning site in the amino-terminal end of the psu gene
By inspection of the nucleotide sequence of the coding start of the psu gene, a unique SacI cleavage site (GAGCTC) can be obtained by changing the three nucleotide sequence (AAG) to (GCT) in the wild-type sequence of psu (GAAAGC) [15] . Such a change will result in two new codons, one of which (CTC) results in an amino acid change from serine to leueine at the third position of the psu reading frame. To construct the SacI site, site-directed mutagenesis was performed after a SphI fragment (3898 bp) of P4 DNA containing the psu gene had been cloned into the vector pALTER-1 (Promega, USA) giving rise to pALTER-I-P4SphI (see Fig. 2 ). pAL-TER-1 is designed for in vitro site-directed mutagenesis. The mutagenesis annealing reaction contained 1.25 pmol phosphorylated 'mutagenic' oligonucleotide (5'-CTGTAAG GCTGTGAGCTCCATCGT-TATCTC-3'), 0.25 pmol phosphorylated ampicillin-'resistant' oligonueleotide (Promega, USA) and 0.05 pmol pALTER-1-P4Sphl single-stranded DNA. The ampicillin-'resistant' oligonucleotide was included to select for the mntagenized strand. The reaction was carried out in 1 × annealing buffer (20 mM Tris-HCI, pH 7.5, 10 mM MgCI 2, 50 ram NaCI) in a final volume of 20/.d, at 70°C for 5 rnin followed by cooling to room temperature over a period of 45 min. Synthesis of the mutant strand was subsequently carried out by adding 3 /zi 10 × synthesis buffer (100 mM Tris • HCI, pH 7.5, 5 mM dNTPs, 10 mM ATP, 20 mM DTI'), 10 U T4 DNA polymerase and 2 U T4 DNA ligase to the annealing reaction (final volume 30/LI) followed by incubation at 37°C for 90 min. Competent BM71-8 cells (Promega, USA), a highly transformable mismatch repair minus strain of Reconstruction of a P4 genome containing the SacI site in the psu gene was performed as shown in Fig. 2 . The presence of the Sacl site in the resulting P4 phage genome was reconfirmed by DNA sequencing. This mutant P4 phage, which harbors a unique Sacl cleavage site in its psu gene, is referred to as P4SacI. The mutagenized Psu, which contained a serine to leucine substitution at the third position from the amino-terminal end, was characterized with regard to its polarity suppression function and its P4 eapsid binding activity. The polarity suppression function was tested by plating P4SacI on the P2 double lysogenic E. coli strain (C-5112), in which one of the prophages carries a polar O amber mutation (OamT1) while the other prophage is defective in the L gene (P2 Lain9). Since the O amber mutation is polar on the L gene, only 1)4 Psu + phage can plate on C-5112 as a result of the polarity suppression effect of Psu [6] . In four separate tests, P4SacI plated with an efficiency of 75-83% compared to P4Psu + phage. This result indicates that the serine to leucine change in Psu has little effect on its polarity suppression function. To test if it still caa bind to the P4 capsid, a high titer stock of P4SacI was grown and the phage particles were purified by CsCI density gradient centrifugation. Presence of Psu in the purified phage preparation was detected by Western blot analysis using anti-Psu antibodies after separation of the P4 proteins by SDS gel eleetrophoresis. The results (not shown) indicated that the modified Psu and the wild-type Psu protein bound equally well to the P4 capsid.
Peptide presentation by P4SaeI
To further test to what extent the aminc terminal end of Psu can tolerate changes in amino acid composition and to explore the possibility of peptide presentation by P4, a 10-amino acid sequence was added The added sequence (EQKLISEEDL) is part of the human p62 c-mye protein and it can be detect.2d by monoelonal antibodies directed against the peptide sequence. The addition of the 10-amino acid sequence was performed by insertion of a synthetic double-stranded oligonucleotide (here given as a single strand: CGGGAGCTCACAGTCAG-3') at the SacI site. This oligo contains two flanking SacI sites and a SacII site. The latter site was included just downstream the c-myc sequence for diagnostic purposes. The SacII site also introduces a proline codon in the joint between the c-myc sequence and the rest of Psu. The double-stranded c-myc oligonucleotide was cleaved with SacI, phosphorylated and ligated to a SacI-digested P4SacI genome. The ligation mixture was subsequently transfected into an E. coli strain lysogenic for P2 (C-353) [5] . Plaques containing the c-myc sequence were identified by plaque lifts followed by DNA hybridization using a 3zP-labelled c-myc-specifie oligonucleotide probe. Several P4c-myc plaques were identified and tested for presence of a SacII cleavage site. The c-myc nucleotide sequence and cloning orientation were determined by DNA sequencing. Of four sequenced isolates, three had the c-myc coding orientation while one contained the reverse orientation (result not shown). Fig.  3 shows a schematic genetic map of the P4c-myc phage.
Presence of the SaclI and SacI cleavage sites in the inserted DNA sequence results in the addition of 14 amino acids to the Psu protein, ten of which represent the c-myc sequence. To examine the effect of the 14 amino acids on polarity 'suppression as well as the capsid binding activity of Psu, P4c-myc phage were subjected to the same tests as described for P4Sacl. Compared to the P4 Psu +, P4c-myc showed 59-61% polarity suppression. When purified P4c-myc particles were subjected to SDS-gel electrophoresis to test for Psu binding to the P4 capsid, the results shown in Fig. 4 were obtained. Psu was detected by anti-Psu (Fig. 4A) or anti-c-myc antibodies (Fig. 4B) . As can be seen (Fig. 4A) , approximately the same amount of Psu is found in the case of P4Psu + and P4c-myc, which indicates that the c-myc containing Psu binds to the P4 capsid. As expected from the addition of 14 amino acids, the P4c-myc Psu migrates slower than Psu +. Fig. 4B shows that the anti c-myc antibodies react specifically with the c-myc amino acid sequence in the PSUc.myc.
To further investigate the peptide presentation ability of P4c-myc, the particles were subjected to a plaque lift followed by detection of the c-myc amino acid sequence by anti-c-myc antibodies. P4Psu + plaques, at the same density as the P4c-myc plaques, were used as control. In a separate experiment, immobilized P4c-myc particles were analysed by ELISA in microtiter plates. In both cases the c-myc amino acid sequence reacted specifically with the anti-c-myc antibodies. The results of the plaque lifts are shown in Fig. 5 (the result of the ELISA test is not shown). Only P4c-myc plaques were detected by the anti e-myc antibody.
robust as the filamentous phages and this property may limit its use in peptide library constructions. This disadvantage, however, may be avoided by high density plaque panning of P4in a similar context as genomie and e-DNA libraries are screened [19] . The transfection ability of P4 peptide displaying genomes will ultimately be the limiting factor for the construction of highly diversified P4 peptide libraries. Under standard conditions, about 10 H infectious P4 particles per ml can be obtained after growth on a P2 lysogenic host. An interesting feature of Psu is its ability to dissociate from the P4 particles. High salt condition seems to promote the dissociation of Psu from the capsids. CsC1 density gradient purification of P4 may therefore result in some loss of Psu from the capsids [20] . In some instances this property of Psu may be useful. In particular, when there is a need to remove the fused peptide-protein complex from the phage particles for further analytical studies. The application of the biosensor system (BIACore or BiaLite, Pharrnaeia Biosensor AB, Uppsala, Sweden) to peptide display by phage, for example, may benefit from such a peptide-protein detachment procedure in order to obtain a more favorable peptide/protein mass ratio.
Finally, the phasmid property of P4 (the ability to propagate as a plasmid as well as a temperate phage) makes it possible to deposit peptide displaying P4 genomes in E. coli, either as an autonomous replicating plasmid or as an integrated prophage, but more work is needed to determine if large proteins can be fused to Psu and carried by infectious P4 particles as well as to evaluate the usefulness of peptide display by phage P4.
Concluding remarks
In this study we have investigated the ability of the P4c-myc phage to express and make the c-myc peptide available for antibody detection. It should be noted, however, that the conditions used for analysis may cause damage to the phage particles, which may lead to dislocation of Psu from its in situ location at the top of the hexamer in the capsid. Hence it remains to be demonstrated that P4 particles presenting peptides as part of Psu can be panned and recovered as infectious particles. P4 is dearly not as
